2015
Bengaluru (India)
Series A
Dozee is a pioneering healthtech company headquartered in Bengaluru, India. It specializes in AI-based contactless remote patient monitoring (RPM) and Early Warning Systems (EWS), revolutionizing healthcare by providing continuous and non-invasive monitoring of vital parameters. Dozee’s innovative solutions aim to bridge critical gaps in patient care, particularly outside intensive care units (ICUs), where traditional monitoring systems often fall short.
Dozee offers cutting-edge solutions designed to enhance patient care:
Dozee Pro: A contactless RPM system using Ballistocardiography and AI algorithms to track vital parameters such as heart rate, respiratory rate, blood pressure, oxygen saturation (SpO2), temperature, and sleep quality with clinical-grade accuracy.
Advance Health Intelligence (AHI): AI-driven algorithms that analyze health trends to provide early alerts for potential deterioration, enabling timely medical intervention.
Mobile App Integration: Seamless connectivity for healthcare providers to monitor patients remotely via web-based platforms and mobile applications.
Dozee’s technology is embedded under mattresses, ensuring comfort while delivering accurate data in real-time. It has proven instrumental in saving lives during emergencies and optimizing nursing efficiency by automating routine monitoring tasks.
Dozee differentiates itself through its contactless approach to patient monitoring, which eliminates the discomfort and limitations of traditional wired systems. By automating vital tracking and providing continuous data streams, it enhances decision-making for healthcare professionals while saving approximately 2.5 nursing hours per patient daily.
Dozee has monitored over 250 billion heartbeats and saved 14 million nursing hours globally. Proven accuracy of 98.4% against clinical-grade sensors. Supported by esteemed organizations like the Bill & Melinda Gates Foundation, Qualcomm, and the Government of India’s BIRAC initiative. Expanded operations to serve over 300 hospitals across India and the US, covering more than 17,000 beds annually. Secured multiple patents, including innovations in micro-vibration mapping for enhanced patient safety.
Dozee operates on a robust business model that combines hardware sales, SaaS subscriptions, and strategic partnerships to drive revenue growth.
Hardware Sales: Revenue from selling Dozee Pro devices to hospitals and healthcare providers.
SaaS Subscriptions: Recurring income from healthcare institutions subscribing to Dozee’s RPM platform for continuous monitoring and analytics.
Service Integration: Monetization through partnerships with hospitals for deploying EWS solutions tailored to their infrastructure needs.
Research Collaborations: Revenue from partnerships with research institutions like NIMHANS for clinical trials and data analysis.
Dozee primarily targets the B2B segment:
Hospitals & Healthcare Providers: Offering RPM systems to improve patient care efficiency.
Public Health Programs: Collaborating with government initiatives to enhance healthcare accessibility.
Research Institutions: Providing advanced tools for studying health trends and outcomes.
Dozee’s growth strategy focuses on:
Market Expansion: Scaling operations across India while penetrating the US market, which faces a critical shortage of nursing staff.
Product Innovation: Continuously enhancing AI algorithms for better accuracy and predictive capabilities.
Strategic Partnerships: Collaborating with healthcare providers and research institutions to expand adoption.
Dozee is redefining healthcare with its innovative AI-based contactless monitoring systems that prioritize patient comfort, accuracy, and efficiency. By addressing critical challenges in traditional patient care infrastructure, Dozee has positioned itself as a leader in RPM solutions globally. With a clear focus on market expansion, product innovation, and strategic collaborations, Dozee represents a promising investment opportunity for stakeholders looking to support transformative advancements in healthcare technology.
$38.1 Million
13
$736 K, Series A
as of March 25, 2025
$121 Million
as of May 31, 2024
3.9
as of May 31, 2024
Prime Venture Partners
and 3 more282
Care.fi
N/A
Date | Round Name | Amount | Valuation | Revenue | Revenue Multiple | Investors |
---|---|---|---|---|---|---|
March 25, 2025 | Series A | $736 K | - | C3H | ||
October 31, 2024 | Series A | $7 Million | $121 Million | Horizons Ventures | ||
January 18, 2024 | Series A | $5.8 Million | $110 Million | $729 K | The Dietrich Foundation, Prime Venture Partners | |
March 24, 2023 | Series A | $6 Million | - | $427 K | J&A Partners Business, Prime Venture Partners, 3one4 Capital, YourNest, Aarem Ventures | |
May 18, 2022 | Series A | $477 K | $92.4 Million | $433 K | General Catalyst | |
May 27, 2021 | Series A | $15.7 Million | - | $365 K | Prime Venture Partners, YourNest, 3one4 Capital, Jain Living Revocable Trust | |
July 3, 2020 | Seed | $1.7 Million | - | $167 K | Prime Venture Partners, YourNest, 3one4 Capital | |
April 10, 2019 | Seed | $394.0K | $2.0M | $37.8K | IKP EDEN | |
April 30, 2018 | Seed | $165 K | - | $51.1K | Aarem Ventures | |
August 29, 2017 | Seed | $79 K | $1.6 Million | $23.6 K | IKP EDEN |
March 25, 2025
December 14, 2024
November 26, 2024